Carregant...

Umbilical Cord-Derived Mesenchymal Stem Cells are Able to Use bFGF Treatment and Represent a Superb Tool for Immunosuppressive Clinical Applications

Mesenchymal stem cells (MSCs) have become a promising tool in cellular therapy for restoring immune system haemostasis; however, the success of clinical trials has been impaired by the lack of standardized manufacturing processes. This study aims to determine the suitability of source tissues and cu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lenka Tesarova, Klara Jaresova, Pavel Simara, Irena Koutna
Format: Artigo
Idioma:Inglês
Publicat: MDPI AG 2020-07-01
Col·lecció:International Journal of Molecular Sciences
Matèries:
Accés en línia:https://www.mdpi.com/1422-0067/21/15/5366
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!